Wanted: FDA-experienced president for Boston Life Sciences:
This article was originally published in Clinica
Executive Summary
Regulatory, FDA and clinical development exposure will be among the qualities sought by Boston Life Sciences as it begins the search for a new president and CEO. The Boston, Massachusetts development-stage biotechnology company, whose portfolio includes the radioimaging agent Altropane, will use its board meeting this Thursday to find a replacement "promptly", following Dr Robert Rosenthal's sudden decision on Monday to resign and develop a new business venture.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.